Literature DB >> 19426925

2008 Santa Fe Bone Symposium: update on osteoporosis.

E Michael Lewiecki1, Sanford Baim, John P Bilezikian, Richard Eastell, Meryl S LeBoff, Paul D Miller.   

Abstract

The Ninth Annual Santa Fe Bone Symposium was held on August 1-2, 2008, in Santa Fe, New Mexico, USA. The symposium faculty presented the current best evidence on selected topics of clinical relevance in the fields of osteoporosis, metabolic bone disease, and assessment of skeletal health. The educational venues were in the form of didactic presentations, panel discussions, challenging cases, and numerous interactive discussions. Knowledge of basic science and clinical trials was applied to real-world patient scenarios that were discussed by faculty experts and clinician participants. Topics included an update on the rationale and development of new agents for the treatment of osteoporosis, the use of bone turnover markers in clinical practice, hospital-based pathways for the management of hip fracture patients, injectable bisphosphonates for the treatment of osteoporosis, combination therapy with anabolic and antiresorptive agents, and assessment of skeletal health with devices other than central dual-energy X-ray absorptiometry. This is a collection of scientific essays based on presentations and discussions at the 2008 Santa Fe Bone Symposium.

Entities:  

Mesh:

Year:  2009        PMID: 19426925     DOI: 10.1016/j.jocd.2009.02.002

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  4 in total

Review 1.  Benefits and limitations of bone mineral density and bone turnover markers to monitor patients treated for osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Curr Osteoporos Rep       Date:  2010-03       Impact factor: 5.096

2.  The dawning age of genetic testing for sports injuries.

Authors:  Gabrielle T Goodlin; Thomas R Roos; Andrew K Roos; Stuart K Kim
Journal:  Clin J Sport Med       Date:  2015-01       Impact factor: 3.638

3.  Relationship between Biochemical Bone Markers and Bone Mineral Density in Patients with Phenylketonuria under Restricted Diet.

Authors:  Hala M Koura; Sherif M Zaki; Nagwa A Ismail; Emad E Salama; Dalia H El Lebedy; Laila K Effat
Journal:  Iran J Pediatr       Date:  2013-12-31       Impact factor: 0.364

4.  Applying personal genetic data to injury risk assessment in athletes.

Authors:  Gabrielle T Goodlin; Andrew K Roos; Thomas R Roos; Claire Hawkins; Sydney Beache; Stephen Baur; Stuart K Kim
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.